-
Rex-Based NADH/NAD+ Biosensor for Bacteria
2026-09-15
Liu, Landick, and Raman developed a genetically encoded, ratiometric NADH/NAD+ biosensor by coupling the redox-responsive bacterial transcription factor Rex to an engineered promoter and fluorescent reporter. The system enabled noninvasive analysis of respiratory-chain mutants, carbon-source effects, and rare high-redox subpopulations, demonstrating a practical route to higher-throughput bacterial redox screening.
-
Gamma-Linolenic Acid: Mechanism-Aware Assays
2026-09-15
Gamma-linolenic acid (GLA) can strengthen anti-inflammatory research when receptor antagonism, lipid metabolism, and cell-state effects are separated experimentally. This guide connects GLA assay design with new evidence on dietary arachidonic acid and humoral immunity while defining practical boundaries for interpretation.
-
Sodium Citrate in 3D SERS Workflows
2026-09-14
Sodium citrate helps researchers tune aqueous chemistry, metal-ion availability, and nanoparticle assembly in polymer pen lithography-based SERS workflows. This guide translates the reference study’s reproducible 3D gold nanocluster strategy into practical preparation, optimization, and troubleshooting decisions.
-
Annexin V-APC/7-AAD Apoptosis Kit in ccRCC
2026-09-14
Learn how the Annexin V-APC/7-AAD Apoptosis Kit can translate glyco-immune checkpoint findings in clear cell renal cell carcinoma into rigorous apoptosis and necrosis measurements. This guide connects phosphatidylserine biology, flow cytometry controls, and mechanism-focused experimental design.
-
CPI-613 Workflows for Tumor Metabolism Studies
2026-09-13
Use CPI-613 to connect mitochondrial carbon metabolism with ATP loss, apoptosis, and chemotherapy response rather than relying on a single viability endpoint. This workflow translates a recent cholangiocarcinoma mechanism into practical assays for tumor cells, macrophages, and combination-treatment studies.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-09-12
This HRP-labeled polyclonal secondary antibody supports detection of mouse-derived primary antibodies in Western blotting, ELISA, IHC, and ICC. It should be used only after confirming mouse-primary compatibility and optimizing dilution, blocking, washing, and substrate conditions; the dossier does not establish universal performance across samples or assay formats.
-
DiscoveryProbe Natural Product Library Plus Workflow
2026-09-12
Build a target-to-cell screening cascade around the DiscoveryProbe Natural Product Library Plus for enzyme inhibition, antiparasitic phenotypes, and pathway-level validation. The workflow uses the Cryptosporidium parvum AdhE study as a benchmark while preserving the distinction between a published reference result and new data generated with L1039P.
-
Cleavage-Resistant TREM2 Restores Macrophage Efferocytosis
2026-09-11
Dong et al. engineered a synthetic cleavage-resistant TREM2 receptor that preserves DAP12-linked signaling when inflammatory ADAM17 activity would otherwise remove TREM2 from the macrophage surface. Phosphatidylserine-functionalized lipid nanoparticles delivered CRT mRNA in situ, improving apoptotic-cell clearance and reducing inflammatory pathology in mouse models of MASH and atherosclerosis.
-
Epacadostat: Reframing IDO1 Translation
2026-09-11
Epacadostat (INCB024360) is more than a potent IDO1 inhibitor: it is a mechanistic probe for linking tryptophan metabolism with immune function. This thought-leadership perspective shows how standardized whole-blood stimulation can strengthen translational immuno-oncology workflows while clarifying the limits between biochemical potency, immune restoration, and tumor response.
-
From Hidden ORFs to Actionable Protein Biology
2026-09-10
Non-canonical ORFs are reshaping how translational researchers investigate cancer biology. This thought-leadership analysis connects the medulloblastoma findings of Hofman and colleagues with a practical strategy for validating microproteins using the 3X (DYKDDDDK) Peptide, while addressing assay design, competitive tag selection, metal sensitivity, and translational limitations.
-
PPACK Dihydrochloride: Assay Architecture
2026-09-10
PPACK Dihydrochloride enables precise separation of thrombin catalysis from downstream platelet receptor signaling. This guide shows how to use its irreversible mechanism, timing, controls, and NF449-based receptor pharmacology to design more interpretable coagulation and platelet assays.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-09
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and selected flow cytometry workflows. It is intended for controlled research assays rather than diagnostic use, and the supplied dossier does not establish performance for every sample type, dilution, or assay format.
-
Fungal IAA Drives Ferroptotic Conidial Death
2026-09-09
This study identifies fungus-derived indole-3-acetic acid (IAA) as a regulator of developmental conidial death in Magnaporthe oryzae. By connecting IAA biosynthesis, phosphatidylethanolamine metabolism, lipid peroxidation, autophagy, appressorium formation, and pathogenicity, the work defines a potential biochemical entry point for rice blast control.
-
Naftifine HCl: Assay Design Beyond the Label
2026-09-08
Naftifine HCl is an allylamine antifungal agent best understood through assay architecture, sterol-biosynthesis readouts, and rigorous controls. This article connects fungal mechanism research with lessons from a WNT5a/GSK3/β-catenin study while clearly defining the limits of cross-domain interpretation.
-
SLU-PP-332: Translating ERR Agonism
2026-09-08
SLU-PP-332 offers a research framework for connecting ERRα, ERRβ, and ERRγ activation with mitochondrial biology, cellular respiration, and metabolic translation. This thought-leadership analysis interprets the available skeletal-muscle evidence, outlines practical assay strategy, and defines the validation steps needed before exercise-mimetic or metabolic claims can move toward clinical relevance.